By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
EntertainmentHeadline

Sreeleela Resumes Shooting for Kartik Aaryan’s Romantic Musical in Mumbai

Last updated: August 16, 2026 12:55 am
Ayesha Masood
Share
Sreeleela Resumes Shooting for Kartik Aaryan’s Romantic Musical in Mumbai
Sreeleela Resumes Shooting for Kartik Aaryan’s Romantic Musical in Mumbai
SHARE

MUMBAI: Actress Sreeleela has resumed shooting in Mumbai for her upcoming romantic musical starring opposite Kartik Aaryan and directed by acclaimed filmmaker Anurag Basu, according to recent reports.

The film, which has faced delays in its production schedule, is now moving forward with Sreeleela completing her remaining portions. An insider quoted by Pinkvilla said the actress has returned to the sets and that the current schedule is progressing as planned.

Sreeleela Begins Her Mumbai Schedule

Sreeleela has reportedly joined the latest Mumbai shooting schedule and is currently filming her portions of the project. The film is being mounted as a large-scale romantic musical, with music expected to play an important role in the storytelling.

Kartik Aaryan has already completed most of his work for the film, with earlier reports suggesting that his portions are more or less finished. The latest schedule is therefore expected to help the production move closer to completion.

Film Was Previously Linked to the Aashiqui Franchise

The project had initially been widely speculated to be Aashiqui 3, which generated considerable interest because of the popularity of the franchise.

However, more recent reports have suggested that the film is titled Tu Meri Zindagi Hai and is being developed as an original romantic story rather than a direct continuation of the Aashiqui franchise. The film is reportedly being scored by composer Pritam, with songs expected to be central to its narrative.

Anurag Basu Directs the Romantic Musical

The film is being directed by Anurag Basu, known for films that combine romance, drama and music in distinctive ways. His involvement has raised expectations for the project, particularly because the upcoming film is being described as an intense romantic musical.

The pairing of Kartik Aaryan and Sreeleela is also attracting attention, as the movie is expected to mark an important milestone in Sreeleela’s Bollywood career.

Sreeleela’s Bollywood Debut

The film is expected to mark Sreeleela’s Bollywood debut as a leading actress. She has already established herself in South Indian cinema and has gained popularity for her performances and dance skills.

Her pairing with Kartik Aaryan has generated significant anticipation among fans, particularly because the project is designed around romance and music.

Production Moves Forward After Delays

The movie had reportedly gone through several delays because of scheduling issues. Earlier reports had indicated that the production team was working toward completing the remaining portions after interruptions to the shooting schedule.

With Sreeleela now back on set in Mumbai, the production appears to be moving forward again. The latest development is expected to bring the film closer to completion and eventually to its theatrical release.

What to Expect

With Anurag Basu at the helm, Kartik Aaryan and Sreeleela in the lead, and Pritam reportedly handling the music, the film is shaping up as one of the more anticipated romantic musicals in Kartik Aaryan’s upcoming lineup.

While an earlier release plan had been discussed for 2026, the film’s production delays mean that its final release schedule should be treated with caution until officially confirmed.

Share This Article
Email Copy Link Print
Previous Article Lahore Police Arrest Daughter of Suspected Target Killer in Targeted Raid Lahore Police Arrest Daughter of Suspected Target Killer in Targeted Raid
Next Article Pavan Malhotra Praises Yami Gautam, Kartik Aaryan and Sanjay Mishra for Their Acting Pavan Malhotra Praises Yami Gautam, Kartik Aaryan and Sanjay Mishra for Their Acting
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
Over 170,000 Canadians sign petition demanding expulsion of US ambassador
Over 170,000 Canadians sign petition demanding expulsion of US ambassador
Headline Politics
August 16, 2026
Hidden Cache: $10 Million in Gold Discovered Beneath Belgian Brewery
Hidden Cache: $10 Million in Gold Discovered Beneath Belgian Brewery
Breaking
August 16, 2026
AJK Election Commission dismisses challenges to Rathore’s LA-17 victory
AJK Election Commission dismisses challenges to Rathore’s LA-17 victory
Headline Politics
August 16, 2026
Anthropic Targets $200B Revenue Goal Ahead of Potential IPO
Anthropic Targets $200B Revenue Goal Ahead of Potential IPO
Headline Technology
August 16, 2026
Kartik Aaryan Invited to President Murmu’s Independence Day Reception
Kartik Aaryan Invited to President Murmu’s Independence Day Reception
Entertainment Headline
August 16, 2026
Pavan Malhotra Praises Yami Gautam, Kartik Aaryan and Sanjay Mishra for Their Acting
Pavan Malhotra Praises Yami Gautam, Kartik Aaryan and Sanjay Mishra for Their Acting
Entertainment Headline
August 16, 2026

You Might Also Like

India Releases Water into Chenab River; Flood Risks Rise in Pakistan
Climate and WeatherHeadline

India Releases Water into Chenab River; Flood Risks Rise in Pakistan

By
Ayesha Masood
England’s Water Crisis: Over Half the Country Officially in Drought
Climate and WeatherHeadline

England’s Water Crisis: Over Half the Country Officially in Drought

By
Ayesha Masood
WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

By
Mabruka Khan
HeadlineSports

New Zealand Set to Launch NZ20 — A New Era of Franchise T20 Cricket

By
Salman Khan
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?